Late gadolinium enhancement confined to the right ventricular insertion points in hypertrophic cardiomyopathy: an intermediate stage phenotype?
Related Experiment Video
Updated: Apr 10, 2026

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
Published on: January 20, 2023
Paco E Bravo1, Hong-Chang Luo2, Iraklis Pozios2
1Department of Cardiology, University of Washington, 1959 NE Pacific Street, PO Box 356422, Seattle, WA 98195, USA Johns Hopkins Medical Institutions, Baltimore, MD, USA pbravo@uw.edu.
Insights
Hypertrophic cardiomyopathy (HCM) patients with right ventricular insertion point (RVIP) late gadolinium enhancement (LGE) show intermediate cardiac function and structure. This RVIP LGE phenotype is distinct from no LGE or left ventricular intramural LGE.
Area of Science:
- Cardiology
- Medical Imaging
- Cardiovascular Disease
Background:
- Hypertrophic cardiomyopathy (HCM) is a complex genetic heart disease.
- Late gadolinium enhancement (LGE) on cardiac MRI is a key imaging biomarker in HCM.
- The distribution of LGE may correlate with disease severity and phenotype.
Purpose of the Study:
- To compare phenotypic characteristics of HCM patients with LGE confined to right ventricular insertion points (RVIP) versus those with no LGE or left ventricular (LV) intramural LGE.
- To investigate the potential of RVIP LGE as an intermediate phenotype in HCM.
Main Methods:
- Cardiac MRI for LGE quantification and LV thickness measurement in 62 HCM patients.
- Classification into three groups: no-LGE (n=18), LGE-RVIP (n=19), and intramural LGE (n=25).
- N-13 ammonia PET for myocardial blood flow (MBF) and myocardial flow reserve (MFR) assessment; echocardiography for LV longitudinal strain.
Main Results:
- LGE extent and LV thickness were significantly higher in the intramural LGE group, intermediate in the LGE-RVIP group, and lowest in the no-LGE group.
- Myocardial blood flow (MBF), myocardial flow reserve (MFR), and LV longitudinal strain were significantly reduced in the intramural LGE group, intermediate in the LGE-RVIP group, and highest in the no-LGE group.
- These findings indicate distinct functional and structural differences across the LGE patterns.
Conclusions:
- HCM patients with LGE restricted to RVIP represent an intermediate phenotype.
- This intermediate phenotype lies between patients with no LGE and those with LV intramural LGE.
- RVIP LGE may signify a distinct stage in HCM progression, identifiable through advanced cardiac imaging.
Aims:
To investigate whether hypertrophic cardiomyopathy (HCM) patients with late gadolinium enhancement (LGE) confined to the right ventricular insertion points (RVIP) differ phenotypically from patients without LGE or intramural LGE in the left ventricle (LV).
Methods And Results:
Sixty-two HCM patients underwent cardiac magnetic resonance for quantification of LGE (% LV mass) and were classified as group (i) no-LGE (n = 18), group (ii) LGE-RVIP (n = 19), and group (iii) intramural LGE (n = 25). All patients also underwent vasodilator N-13 ammonia PET to quantify myocardial blood flow (MBF) and myocardial flow reserve (MFR), and echocardiography to measure longitudinal LV strain. LGE extent (17 ± 11% vs. 4 ± 4% vs. 0%; P < 0.001) and LV thickness (21.7 ± 3.4 vs. 18.8 ± 3.9 vs. 16.3 ± 2.8 mm; P < 0.001) were significantly greater in group 3, intermediate in group 2, and lower in group 1. In contrast, stress MBF (1.62 ± 0.44 vs. 1.90 ± 0.37 vs. 2.22 ± 0.48 mL/min/g; P < 0.001); MFR (1.92 ± 0.47 vs. 2.15 ± 0.52 vs. 2.71 ± 0.52; P < 0.001), and longitudinal LV strain (-11.4 ± 3.8 vs. -12.6 ± 3.2 vs. -14.4 ± 4.1%; P = 0.04) were lower in group 3, intermediate in group 2, and higher in group 1.
Conclusions:
From an imaging viewpoint, patients with LGE confined to only the RVIP appear to represent an intermediate-stage phenotype between patients with no LGE and intramural LGE in the LV.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Cardiomyopathy I: Introduction and Classification
Mitral Regurgitation I: Introduction

